
    
      Description: The purpose of this study is to evaluate efficacy and safety of
      mFOLFOX6+bevacizumab and mFOLFOX6+cetuximab for liver only metastasis from KRAS Exon 2 wild
      type (under protocol 1.0-1.2 edition) and RAS wild type (under protocol 2.0 edition)
      colorectal cancer.
    
  